Social Media

Living with Hope After an ATTR-Cardiac Amyloidosis (ATTR-CM) Diagnosis

Jul 02, 2026

Many heart failure patients are still not consistently identified early enough and – that gap matters

Jul 01, 2026

doctortim.md

Jun 30, 2026

How Many ATTR-CM Patients Are We Still Missing?

Jun 30, 2026

Radcliffe Cardiology's Post

Jun 29, 2026

A Former Orchestra Conductor’s Path to Treatment

Jun 27, 2026

amyloidosis_alliance

Jun 27, 2026

amyloidosis_alliance

Jun 26, 2026

howardhwhite

Jun 25, 2026

When to Suspect ATTR-CM: Clues for Earlier Diagnosis

Jun 25, 2026

Myra Zuccolo's Post

Subscribe to

RNAi Explained

Dr. Bersell explores RNA interference (RNAi) technology and its applications in treating ATTR-CM and ATTR-PN. Learn about mechanism of action, clinical evidence, and patient outcomes.

Learn More

Expert Perspectives on Attruby®

Dr. Barry Trachtenberg and ATTR community members discuss Attruby™ (acoramidis), covering clinical data, patient perspectives, and treatment considerations.

Watch Discussion